Clinical Trial Results:
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral
OPC-34712 as Monotherapy in Adult Patients with Schizophrenia
Summary
|
|
EudraCT number |
2009-012568-14 |
Trial protocol |
SK BG |
Global completion date |
30 Mar 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1 |
This version publication date |
10 Nov 2016
|
First version publication date |
10 Nov 2016
|
Other versions |
v2 |
Summary report(s) |
331-08-210 CSR Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.